CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Overview Fund Activity
Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

98 hedge funds and large institutions have $110M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+8
Holders Change %
+8.89%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
36
Reduced
17
Closed
15
Calls
$3.17M
Puts
$683K
Net Calls
+$2.48M
Net Calls Change
+$278K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$15M
2
State Street
State Street
Massachusetts
$19.4M
3
Millennium Management
Millennium Management
New York
$8.98M
4
Vanguard Group
Vanguard Group
Pennsylvania
$9.72M
5
OAM
Oxford Asset Management
United Kingdom
$1.27M

Top Sellers

1
EAM
Eagle Asset Management
Florida
$7.84M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$0
3
RCM
RA Capital Management
Massachusetts
$0
4
DCM
DAFNA Capital Management
California
$0
5
ACP
Acuta Capital Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LOAMU
101
Lombard Odier Asset Management (USA)
New York
– -$1.18M -50,144 Closed
CCMH
102
Cornerstone Capital Management Holdings
New York
– -$221K -9,380 Closed
CIA
103
Capital Impact Advisors
Massachusetts
– -$128K -5,420 Closed
RCM
104
Rotella Capital Management
Washington
– -$63K -2,659 Closed
CCS
105
Crosspoint Capital Strategies
California
– -$59K -2,500 Closed
GCP
106
GSA Capital Partners
United Kingdom
– -$38K -1,621 Closed
EWM
107
Edge Wealth Management
New York
– -$19K -800 Closed
1 2 3 4
5